EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 184 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,713,000 | +43.6% | 22,636 | +0.0% | 0.21% | +36.3% |
| Q1 2018 | $1,193,000 | -10.4% | 22,634 | -9.2% | 0.16% | -10.8% |
| Q4 2017 | $1,332,000 | -7.9% | 24,935 | +2.8% | 0.18% | -10.7% |
| Q3 2017 | $1,447,000 | -33.0% | 24,265 | -11.3% | 0.20% | -36.2% |
| Q2 2017 | $2,159,000 | +18.4% | 27,361 | +24.4% | 0.31% | +8.0% |
| Q1 2017 | $1,824,000 | +17.3% | 21,994 | +12.2% | 0.29% | +11.7% |
| Q4 2016 | $1,555,000 | +53.1% | 19,603 | +35.0% | 0.26% | +56.1% |
| Q3 2016 | $1,016,000 | – | 14,521 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |